Loading
Life sciences · Journal article
Acs Applied Materials & Interfaces · October 19, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Photothermal therapy has attracted extensive attention in tumor treatment owing to its spatiotemporal controllability and noninvasiveness. However, the nonselective “always on” nature of traditional photothermal nanoagents together with the intrinsic thermal resistance within tumor cells has hampered the therapeutic efficacy. Herein, we developed a tumor-microenvironment-responsive transformable prenanotherapeutic platform with a polyethyleneimine (PEI)-coated tannic acid-Ca2+ chelate core and an outer shell of Fe2+-doped ZIF-90, which enabled the in situ generation of photothermal agents, synchronous activation of multiple therapeutic modalities, as well as cascaded synergistic enhancement of antitumor potency. First, degradation triggered by high-concentration adenosine triphosphate (ATP) and mild acidity within tumor cells liberated Fe2+ to catalyze hydroxyl radical (·OH) production for chemodynamic therapy. Meanwhile, the generated Fe3+ readily underwent in situ self-assembly with tannic acid to form photothermal agents, which competitively released Ca2+ and induced calcium overload. Subsequently, the dual mitochondrial destruction pathway induced by ·OH and excess Ca2+ suppressed ATP synthesis, which further downregulated the expression of heat shock protein 70 and elevated tumor cell thermosensitivity to realize mild photothermal therapy. Moreover, heat generated via photothermal agents enhanced the efficiency of Fenton-like reactions for robust ·OH accumulation, further improving the therapeutic efficacy. In vitro experiments revealed the underlying synergistic antitumor mechanism, while in vivo experiments confirmed the remarkable tumor suppression capacity of the nanomaterial. Notably, an intelligent TME-responsive “OFF-to-ON” multifunctional nanoplatform was fabricated on the basis of differential binding affinities of metal ions and polyphenols, offering a safer, more efficient and precise strategy for synergistic cancer therapy.